Systemic Lupus Erythematosus Disease Activity Index (SLEDAI-2K) Responder Index (SRI)-50: a Valid Index for Measuring Improvement in Disease Activity

被引：0
|
作者：
Touma, Zahi [1 ]
Gladman, Dafna [1 ]
Ibanez, Dominique [1 ]
Urowitz, Murray [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1169 / 1170
页数：2
相关论文
共 50 条
  • [21] A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    HAWKER, G
    GABRIEL, S
    BOMBARDIER, C
    GOLDSMITH, C
    CARON, D
    GLADMAN, D
    [J]. JOURNAL OF RHEUMATOLOGY, 1993, 20 (04) : 657 - 660
  • [22] PERFORMANCE OF SLEDAI-2K RESPONDER INDEX-50 IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL WITH USTEKINUMAB (UST) IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Touma, Zahi
    Gladman, Dafna
    Fei, Kaiyin
    Gregan, Irene
    Zazzetti, Federico
    Gordon, Robert
    Lo, Kim Hung
    Rose, Shawn
    Urowitz, Murray
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S39 - S39
  • [23] SLE Disease Activity Index Glucocorticosteroid Index (SLEDAI-2KG) Identifies More Responders Than Sledai-2K
    Touma, Zahi
    Gladman, Dafna D.
    Su, Jiandong
    Anderson, Nicole
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Enhances the Ability of SLE Responder Index to Identify Responders in Clinical Trials
    Touma, Zahi
    Gladman, Dafna D.
    Ibanez, Dominique
    Taghavi-Zadeh, Shahrzad
    Urowitz, Murray B.
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2395 - 2399
  • [25] EARLY IMPROVEMENT IN SLEDAI-2K RESPONDER INDEX-50 PREDICTS SRI-4 RESPONSE IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF USTEKINUMAB (UST) IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Touma, Zahi
    Gladman, Dafna D.
    Rose, Shawn
    Fei, Kaiyin
    Gregan, Y. Irene
    Gordon, Robert
    Lo, Kim Hung
    Urowitz, Murray B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 402 - 403
  • [26] Early Improvement in SLEDAI-2K Responder Index-50 Predicts SRI-4 Response in a Randomized Placebo-Controlled Trial of Ustekinumab (UST) in Systemic Lupus Erythematosus
    Touma, Zahi
    Gladman, Dafna
    Rose, Shawn
    Fei, Kaiyin
    Gregan, Yun
    Gordon, Robert
    Lo, Kim Hung
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Development and Assessment of Users' Satisfaction with the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Website
    Touma, Zahi
    Gladman, Dafna D.
    MacKinnon, Anne
    Carette, Simon
    Abu-Shakra, Mahmoud
    Askanase, Anca
    Nived, Ola
    Hanly, John G.
    Landolt-Marticorena, Carolina
    Tam, Lai-Shan
    Toloza, Sergio
    Nikpour, Mandana
    Riddell, Claire
    Stelman, Amanda
    Eder, Lihi
    Haddad, Amir
    Barber, Claire
    Urowitz, Murray B.
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (01) : 34 - 39
  • [28] Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage
    Brunner, HI
    Jones, OY
    Lovell, DJ
    Johnson, AM
    Alexander, P
    Klein-Gitelman, MS
    [J]. LUPUS, 2003, 12 (08) : 600 - 606
  • [29] Identifying Response for the Systemic Lupus Erythematosus Disease Activity Glucocorticoid Index (SLEDAI-2KG)
    Touma, Zahi
    Gladman, Dafna D.
    Su, Jiandong
    Anderson, Nicole
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Evaluation of the Lupus Low Disease Activity State (LLDAS) vs. the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)-2K Score in a Pediatric Systemic Lupus Erythematosus Cohort
    Wilson, Bridget
    Qiu, Tingting
    Merritt, Angela
    Huang, Bin
    Brunner, Hermine
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1570 - 1573
12345